Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
暂无分享,去创建一个
M. Socinski | R. Kurek | Michael Thomas | J. von Pawel | R. Pirker | J. Schiller | G. Kloecker | M. Sebastian | P. Schütt | M. Saleh | C. Beadman | T. Marsland | R. Ansari | R. McCroskey | W. Pfeifer | M. Saleh